medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/10.24835/1607-0763-1090medvis-1090Research ArticleОТ ПРИГЛАШЕННОГО РЕДАКТОРАFROM THE INVITED EDITORСовременный взгляд на принципы диагностики рака молочной железы по данным контрастной маммографии (обзор литературы)Modern view on the principles of breast cancer diagnostics using contrast mammography (literature review)https://orcid.org/0000-0002-7757-6273БаженоваД. А.BazhenovaD. A.

Баженова Дарья Анатольевна – аспирант кафедры лучевой диагностики и лучевой терапии, врач-рентгенолог отделения рентгенодиагностики с кабинетами МРТ и КТ

119192 Москва, Ломоносовский проспект, 27, к.10

Daria A. Bazhenova – PhD Student at Radiology department; Radiologist at Radiology department with CT and MRI 

27-10, Lomonosovsky prospekt, 119192 Moscow

bazhenova.darya@gmail.comhttps://orcid.org/0000-0002-1266-4926МершинаЕ. А.MershinaE. A.

Мершина Елена Александровна – канд. мед. наук, доцент кафедры лучевой диагностики и лучевой терапии, заведующая отделением рентгенодиагностики с кабинетами МРТ и КТ

119192 Москва, Ломоносовский проспект, 27, к.10

Elena A. Mershina – Cand. of Sci. (Med.), Assistant Professor of Radiology department, Medical Research and Educational Center, Head of Radiology department 

27-10, Lomonosovsky prospekt, 119192 Moscow

elena_mershina@mail.ruhttps://orcid.org/0000-0002-5312-1557ПучковаО. С.PuchkovaO. S.

Пучкова Ольга Сергеевна – врач-рентгенолог отделения рентгенодиагностики с кабинетами МРТ и КТ

119192 Москва, Ломоносовский проспект, 27, к.10

Ol’ga S. Puchkova – Radiologist at Radiology department with CT and MRI 

27-10, Lomonosovsky prospekt, 119192 Moscow

helgasoul@yandex.ruhttps://orcid.org/0000-0001-7608-2725СенниковИ. С.SennikovI. S.

Сенников Игорь Сергеевич – врач-рентгенолог отделения рентгенодиагностики с кабинетами МРТ и КТ

119192 Москва, Ломоносовский проспект, 27, к.10

Igor’ S. Sennikov – Radiologist at Radiology department with CT and MRI 

27-10, Lomonosovsky prospekt, 119192 Moscow

drsennikov@yandex.ruhttps://orcid.org/0000-0002-0894-1994ФилатоваД. А.FilatovaD. A.

Филатова Дарья Андреевна – клинический ординатор кафедры лучевой диагностики и лучевой терапии

119192 Москва, Ломоносовский проспект, 27, к.10

Darya A. Filatova – Resident of Radiology and Radiotherapy Department  

27-10, Lomonosovsky prospekt, 119192 Moscow

vsini@mail.ruМедицинский научно-образовательный центр ФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”РоссияMedical Research and Education Center of Lomonosov Moscow State UniversityRussian Federation2022050320222614047Copyright © Баженова Д.А., Мершина Е.А., Пучкова О.С., Сенников И.С., Филатова Д.А., 20222022Баженова Д.А., Мершина Е.А., Пучкова О.С., Сенников И.С., Филатова Д.А.Bazhenova D.A., Mershina E.A., Puchkova O.S., Sennikov I.S., Filatova D.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.rdsmedia.ru/jour/article/view/1090

В статье рассматриваются последние достижения лучевой диагностики при обследовании пациенток с предполагаемым раком молочной железы на различных этапах диагностики. Описываются возможности двухэнергетической контрастной спектральной маммографии, магнитно-резонансной томографии в первичной диагностике заболевания и при оценке распространенности процесса, вовлеченности контралатеральной молочной железы, обсуждаются оптимальная методика проведения исследования и принципы интерпретации полученных данных в ежедневной практике.

The article discusses the latest achievements of radiation diagnostics in the examination of patients with suspected breast cancer at various stages. The possibilities of dual-energy contrast spectral mammography, magnetic resonance imaging in the primary diagnosis of the disease and in assessing the prevalence of the process, the involvement of the contralateral breast, the optimal methodology of the study and the principles of interpretation of the data obtained in daily practice are discussed.

рак молочной железыдиагностикадвухэнергетическая контрастная спектральная маммо графиямагнитно-резонансная томографияbreast cancerdiagnosticsdual-energy contrast spectral mammographymagnetic resonance imagingРабота выполнена в рамках государственного задания МГУ (номер ЦИТИС 121061800148-2).ReferencesLewin J.M., Isaacs P.K., Vance V., Larke F.J. Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology. 2003; 229 (1): 261–268. http://doi.org/10.1148/radiol.2291021276Lewin J.M., Isaacs P.K., Vance V., Larke F.J. Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology. 2003; 229 (1): 261–268. http://doi.org/10.1148/radiol.2291021276Dromain C., Thibault F., Muller S. et al. Dual-energy contrast-enhan ced digital mammography: initial clinical results. Eur. Radiol. 2011; 21 (3): 565–574. http://doi.org/10.1007/s00330-010-1944-yDromain C., Thibault F., Muller S. et al. Dual-energy contrast-enhan ced digital mammography: initial clinical results. Eur. Radiol. 2011; 21 (3): 565–574. http://doi.org/10.1007/s00330-010-1944-yJochelson M.S., Dershaw D.D., Sung J.S. et al. Bilateral contrast-enhanced dual-energy digital mammo graphy: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology. 2013; 266 (3): 743–751. http://doi.org/10.1148/radiol.12121084Jochelson M.S., Dershaw D.D., Sung J.S. et al. Bilateral contrast-enhanced dual-energy digital mammo graphy: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology. 2013; 266 (3): 743–751. http://doi.org/10.1148/radiol.12121084Daniaux M., De Zordo T., Santner W. et al. Dual-energy contrast-enhanced spectral mammography (CESM). Arch. Gynecol. Obstet. 2015; 292 (4): 739–747. http://doi.org/10.1007/s00404-015-3693-2Daniaux M., De Zordo T., Santner W. et al. Dual-energy contrast-enhanced spectral mammography (CESM). Arch. Gynecol. Obstet. 2015; 292 (4): 739–747. http://doi.org/10.1007/s00404-015-3693-2Cheung Y.C., Lin Y.C., Wan Y.L. et al. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis. Eur. Radiol. 2014; 24 (10): 2394–2403. http://doi.org/10.1007/s00330-014-3271-1Cheung Y.C., Lin Y.C., Wan Y.L. et al. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis. Eur. Radiol. 2014; 24 (10): 2394–2403. http://doi.org/10.1007/s00330-014-3271-1Fallenberg E.M., Dromain C., Diekmann F. et al. Contrastenhanced spectral mammo graphy versus MRI: Initial results in the detection of breast cancer and assessment of tumour size. Eur. Radiol. 2014; 24 (1): 256–264. http://doi.org/10.1007/s00330-013-3007-7Fallenberg E.M., Dromain C., Diekmann F. et al. Contrastenhanced spectral mammo graphy versus MRI: Initial results in the detection of breast cancer and assessment of tumour size. Eur. Radiol. 2014; 24 (1): 256–264. http://doi.org/10.1007/s00330-013-3007-7Lobbes M.B., Lalji U., Houwers J. et al. Contrast-enhanced spectral mammo graphy in patients referred from the breast cancer screening programme. Eur. Radiol. 2014; 24 (7): 1668–1676. http://doi.org/10.1007/s00330-014-3154-5Lobbes M.B., Lalji U., Houwers J. et al. Contrast-enhanced spectral mammo graphy in patients referred from the breast cancer screening programme. Eur. Radiol. 2014; 24 (7): 1668–1676. http://doi.org/10.1007/s00330-014-3154-5Wernli K.J., DeMartini W.B., Ichikawa L. et al.; Breast Cancer Surveillance Consortium. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern. Med. 2014; 174 (1): 125–132. http://doi.org/10.1001/jamainternmed.2013.11963Wernli K.J., DeMartini W.B., Ichikawa L. et al.; Breast Cancer Surveillance Consortium. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern. Med. 2014; 174 (1): 125–132. http://doi.org/10.1001/jamainternmed.2013.11963Cott Chubiz J.E., Lee J.M., Gilmore M.E. et al. Costeffectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer. 2013; 119 (6): 1266–1276. http://doi.org/10.1002/cncr.27864Cott Chubiz J.E., Lee J.M., Gilmore M.E. et al. Costeffectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer. 2013; 119 (6): 1266–1276. http://doi.org/10.1002/cncr.27864Kuhl C.K., Schrading S., Strobel K. et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2014; 32 (22): 2304–2310. http://doi.org/10.1200/JCO.2013.52.5386Kuhl C.K., Schrading S., Strobel K. et al. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2014; 32 (22): 2304–2310. http://doi.org/10.1200/JCO.2013.52.5386Łuczyńska E., Heinze-Paluchowska S., Hendrick E. et al. Comparison between breast MRI and contrast-enhanced spectral mammography. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2015; 21: 1358–1367. http://doi.org/10.12659/MSM.893018Łuczyńska E., Heinze-Paluchowska S., Hendrick E. et al. Comparison between breast MRI and contrast-enhanced spectral mammography. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2015; 21: 1358–1367. http://doi.org/10.12659/MSM.893018Helal M.H., Mansour S.M., Ahmed H.A. et al. The role of contrast-enhanced spectral mammography in the evaluation of the postoperative breast cancer. Clin Radiol. 2019; 74 (10): 771–781. http://doi.org/10.1016/j.crad.2019.06.002Helal M.H., Mansour S.M., Ahmed H.A. et al. The role of contrast-enhanced spectral mammography in the evaluation of the postoperative breast cancer. Clin Radiol. 2019; 74 (10): 771–781. http://doi.org/10.1016/j.crad.2019.06.002Hobbs M.M., Taylor D.B., Buzynski S., Peake R.E. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance. J. Med. Imaging Radiat. Oncol. 2015; 59 (3): 300–305. http://doi.org/10.1111/1754-9485.12296Hobbs M.M., Taylor D.B., Buzynski S., Peake R.E. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance. J. Med. Imaging Radiat. Oncol. 2015; 59 (3): 300–305. http://doi.org/10.1111/1754-9485.12296Оксанчук Е.А., Колесник А.Ю., Меских Е.В. Контрастная маммография в дифференциальной диагностике заболеваний молочных желез: первые результаты. Res. Pract. Med. J. 2017; S2: 73. Oksanchuk E.A., Kolesnik A.Y., Meskih E.V. The role of contrast-enhanced mammography for determining breast lesions: the first results. Res. Pract. Med. J. 2017; S2: 73.Оксанчук Е.А., Колесник А.Ю., Меских Е.В. Контрастная маммография в дифференциальной диагностике заболеваний молочных желез: первые результаты. Res. Pract. Med. J. 2017; S2: 73. Oksanchuk E.A., Kolesnik A.Y., Meskih E.V. The role of contrast-enhanced mammography for determining breast lesions: the first results. Res. Pract. Med. J. 2017; S2: 73.Okada N., Tatsugami F., Sugai M. et al. The feasibility of contrast-enhanced spectral mammography immediately after contrast-enhanced CT. Radiol. Phys. Technol. 2019; 12 (3): 277–282. http://doi.org/10.1007/s12194-019-00518-6Okada N., Tatsugami F., Sugai M. et al. The feasibility of contrast-enhanced spectral mammography immediately after contrast-enhanced CT. Radiol. Phys. Technol. 2019; 12 (3): 277–282. http://doi.org/10.1007/s12194-019-00518-6La Forgia D., Catino A., Dentamaro R. et al. Role of the contrast-enhanced spectral mammography for the diagnosis of breast metastases from extramammary neoplasms. J. BUON Off. J. Balk. Union Oncol. 2019; 24 (4): 1360–1366.La Forgia D., Catino A., Dentamaro R. et al. Role of the contrast-enhanced spectral mammography for the diagnosis of breast metastases from extramammary neoplasms. J. BUON Off. J. Balk. Union Oncol. 2019; 24 (4): 1360–1366.Belli P., Costantini M., Romani M. et al. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res. Treat. 2002; 73 (3): 223–235. http://doi.org/10.1023/a:1015868406986Belli P., Costantini M., Romani M. et al. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res. Treat. 2002; 73 (3): 223–235. http://doi.org/10.1023/a:1015868406986Fanizzi A., Losurdo L., Basile T.M.A. et al. Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images. J. Clin. Med. 2019; 8 (6): E891. http://doi.org/10.3390/jcm8060891Fanizzi A., Losurdo L., Basile T.M.A. et al. Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images. J. Clin. Med. 2019; 8 (6): E891. http://doi.org/10.3390/jcm8060891

The authors declare that there are no conflicts of interest present.